{"id":10372,"date":"2026-06-30T10:33:30","date_gmt":"2026-06-30T02:33:30","guid":{"rendered":"https:\/\/regask.com\/?p=10372"},"modified":"2026-06-30T10:33:30","modified_gmt":"2026-06-30T02:33:30","slug":"gmp-enforcement-june-2026","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/gmp-enforcement-june-2026\/","title":{"rendered":"Die Durchsetzung der GMP-Richtlinien versch\u00e4rft sich: Warnschreiben der FDA, Importbestimmungen \u2026"},"content":{"rendered":"<p id=\"ember1956\" class=\"ember-view reader-text-block__paragraph\"><span class=\"TextRun SCXW61959956 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW61959956 BCX0\"><strong>GMP enforcement escalated noticeably in mid-2026, and manufacturing inspections carried the highest share of risky regulatory alerts among our top Life Sciences trends.<\/strong> The driver was a clear surge in US FDA action\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">(<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">a run of CGMP warning letters paired with expanded import detentions<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">)<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0alongside inspection activity in Japan and Latin America. For manufacturing and quality teams, this is the trend with the most direct operational consequence: enforcement here\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">doesn&#8217;t<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0just generate\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">paperwork;<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0it stops\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">Produkt<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0shipping.<\/span><\/span><span class=\"EOP Selected SCXW61959956 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:0,&quot;335559739&quot;:0}\">\u00a0<\/span><\/p>\n\t<div id=\"gap-1789194702\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1789194702 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h3><strong><span class=\"TextRun MacChromeBold SCXW170068198 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW170068198 BCX0\">The FDA escalated CGMP warning letters and import alerts<\/span><\/span><\/strong><\/h3>\n\t<div id=\"gap-2009464135\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2009464135 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"NormalTextRun SCXW80589066 BCX0\">The FDA issued a wave of warning letters citing significant CGMP deficiencies\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">(<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">across sterile manufacturing, active pharmaceutical ingredient (API) production, and outsourcing facilities<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">)\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">and expanded detention without physical examination for GMP-noncompliant drugs at the border. The pairing is what makes it serious: a warning letter damages a site&#8217;s standing, while import detention turns a compliance finding into an immediate\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">supply of<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">\u00a0interruption. Sterile assurance, data integrity, and API controls recurred across the letters<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">,\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">precisely where remediation is slowest. A site on an import alert can be blocked from the US market long before the underlying issues are resolved.<\/span><\/p>\n<h3><strong><span class=\"TextRun MacChromeBold SCXW76108789 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW76108789 BCX0\">Japan&#8217;s PMDA published GMP inspection findings<\/span><\/span><\/strong><\/h3>\n\t<div id=\"gap-1547867687\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1547867687 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"NormalTextRun SCXW28283816 BCX0\">Japan&#8217;s PMDA released a GMP inspection case report focused on active pharmaceutical ingredient management. Case reports are quietly valuable in a way generic guidance is not: they show inspectors&#8217; actual expectations and the specific failure modes they flag, which is far more actionable than principles in the abstract. Quality teams should mine reports like this for the concrete control points inspectors care about\u00a0<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">(<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">sampling, documentation, supplier qualification<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">)<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">\u00a0and benchmark their own API oversight against the findings before an inspector does.<\/span><\/p>\n<h3><strong><span class=\"TextRun MacChromeBold SCXW154821105 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW154821105 BCX0\">The Dominican Republic extended inspections to imported medicines<\/span><\/span><\/strong><\/h3>\n\t<div id=\"gap-2122402859\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2122402859 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW41450848 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW41450848 BCX0\">The Dominican Republic&#8217;s DIGEMAPS extended its GMP inspection guidance to foreign-manufactured and imported medicines. Extending scope to foreign sites is part of a broader regional pattern: regulators increasingly want assurance over the whole manufacturing chain, not just domestic facilities. For manufacturers exporting into these markets, a foreign site&#8217;s GMP status can now\u00a0<\/span><span class=\"NormalTextRun SCXW41450848 BCX0\">bestimmen<\/span><span class=\"NormalTextRun SCXW41450848 BCX0\"> access in places that previously relied on the exporting country&#8217;s oversight, and a problem at one plant can close several markets at once.<\/span><\/span><span class=\"EOP SCXW41450848 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:0,&quot;335559739&quot;:0}\">\u00a0<\/span><\/p>\n<h3><strong><span class=\"NormalTextRun SCXW224609958 BCX0\">Was\u00a0<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">tut dies<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">\u00a0<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">bedeuten<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">\u00a0f\u00fcr\u00a0<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">manufacturers?<\/span><\/strong><\/h3>\n\t<div id=\"gap-1798602223\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1798602223 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"NormalTextRun SCXW116620405 BCX0\">With the FDA escalating at and beyond its border and inspectorates in Japan and Latin America widening their reach, GMP enforcement is both intensifying and <\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">globalizing<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">. Pressure-test the controls regulators are\u00a0<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">citing<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">\u00a0<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">(<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">sterile assurance, data integrity, and API management<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">)<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">\u00a0and confirm import-compliance status before shipments are detained. In a tightening climate, the cost of a GMP gap is measured in stopped product and closed markets, not just remediation hours.\u00a0<\/span><a href=\"http:\/\/regask.com\/de\/\"><strong><span class=\"NormalTextRun SpellingErrorV2Themed SCXW116620405 BCX0\">RegASK<\/span><\/strong><\/a><span class=\"NormalTextRun SCXW116620405 BCX0\">\u00a0tracks GMP inspection outcomes, warning letters, and import alerts across global regulators, helping manufacturing and quality teams stay ahead of escalating enforcement.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>GMP enforcement escalated noticeably in mid-2026, and manufacturing inspections carried the highest share of risky regulatory alerts among our top Life Sciences trends. The driver was a clear surge in US FDA action\u00a0(a run of CGMP warning letters paired with expanded import detentions)\u00a0alongside inspection activity in Japan and Latin America. For manufacturing and quality teams,&#8230;<\/p>","protected":false},"author":46,"featured_media":10375,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10372","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blogs"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>GMP Enforcement 2026: Key Regulatory Changes Ahead<\/title>\n<meta name=\"description\" content=\"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/gmp-enforcement-june-2026\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GMP Enforcement Escalates: FDA Warning Letters, Import Alerts &amp; Global Inspections\" \/>\n<meta property=\"og:description\" content=\"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/gmp-enforcement-june-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-30T02:33:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shaffa Renaningtyas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaffa Renaningtyas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\"},\"author\":{\"name\":\"Shaffa Renaningtyas\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/6d86c29c9123b2b67a3ea8e259cdb925\"},\"headline\":\"GMP Enforcement Escalates: FDA Warning Letters, Import &hellip;\",\"datePublished\":\"2026-06-30T02:33:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\"},\"wordCount\":504,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"articleSection\":[\"Blogs\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\",\"name\":\"GMP Enforcement 2026: Key Regulatory Changes Ahead\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"datePublished\":\"2026-06-30T02:33:30+00:00\",\"description\":\"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"width\":800,\"height\":600,\"caption\":\"Gmp Enforcement Escalates Fda Warning Letters Import Alerts & Global Inspections\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/6d86c29c9123b2b67a3ea8e259cdb925\",\"name\":\"Shaffa Renaningtyas\",\"sameAs\":[\"https:\\\/\\\/regask.com\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GMP Enforcement 2026: Key Regulatory Changes Ahead","description":"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/gmp-enforcement-june-2026\/","og_locale":"de_DE","og_type":"article","og_title":"GMP Enforcement Escalates: FDA Warning Letters, Import Alerts & Global Inspections","og_description":"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.","og_url":"https:\/\/regask.com\/de\/gmp-enforcement-june-2026\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-06-30T02:33:30+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","type":"image\/png"}],"author":"Shaffa Renaningtyas","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Shaffa Renaningtyas","Est. reading time":"3\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#article","isPartOf":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/"},"author":{"name":"Shaffa Renaningtyas","@id":"https:\/\/regask.com\/#\/schema\/person\/6d86c29c9123b2b67a3ea8e259cdb925"},"headline":"GMP Enforcement Escalates: FDA Warning Letters, Import &hellip;","datePublished":"2026-06-30T02:33:30+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/"},"wordCount":504,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","articleSection":["Blogs"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/","url":"https:\/\/regask.com\/gmp-enforcement-june-2026\/","name":"GMP Enforcement 2026: Key Regulatory Changes Ahead","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","datePublished":"2026-06-30T02:33:30+00:00","description":"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/gmp-enforcement-june-2026\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","width":800,"height":600,"caption":"Gmp Enforcement Escalates Fda Warning Letters Import Alerts & Global Inspections"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/6d86c29c9123b2b67a3ea8e259cdb925","name":"Shaffa Renaningtyas","sameAs":["https:\/\/regask.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/10372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/46"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=10372"}],"version-history":[{"count":3,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/10372\/revisions"}],"predecessor-version":[{"id":10376,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/10372\/revisions\/10376"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/10375"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=10372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=10372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=10372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}